Abstract
Objective: The aim of this study was to examine changes over four decades in children's psychological problems managed in Australian general practice and to describe recent management of these problems.
Method: Analysis of GP encounters with children, using data from the BEACH study, an on-going, cross-sectional, national survey of general practice, provides contemporary results. Comparisons with two related studies: 1970–1971 (from published reports), and 1990–1991 (secondary analysis), describe changes over time.
Results: Changes over time: psychological problems accounted for 2% of all children's problems managed in 1971, 1.3% in 1990–1991 and 2.6% in 2008–2009. In 1971, non-organic enuresis accounted for 30% of children's psychological problems but only 2.7% in 2008–2009. Insomnia showed a similar pattern. Between 1990–1991 and 2008–2009, ADHD increased from 0.8% to 14.7%, and from 2000–2001 to 2008–2009, autism spectrum disorders rose from 4.9% to 11%. Current practice: most common psychological problems managed for children less than 18 years were anxiety, depression, intellectual impairment and ADHD. Among children aged 0–5 years, sleep disturbance and intellectual impairment were the main problems, for 6–11 year olds, anxiety and ADHD, and for 12–17 year olds, depression. Boys were significantly more likely to be managed for intellectual impairment, ADHD and autism spectrum disorders than were girls, who were more likely to be managed for depression. The medication rate was low at 19 per 100 psychological problems although higher for depression and ADHD. Referrals were given at a high rate. Counselling was also provided often, except in management of ADHD.
Conclusions: Access to the three studies allowed consideration of trends over a forty year period, showing the development of newly defined conditions which have replaced childhood diagnoses of past decades. The results demonstrate that GP involvement in children's mental health care management has grown significantly over the past 20 years.
Acknowledgements
The authors thank the GP participants in the BEACH programme and all members of the BEACH team.
Declaration of interest: The following organizations supported BEACH during 2000–2001 and 2008–2009: Australian Government Department of Health and Ageing, Australian Institute of Health and Welfare, National Prescribing Service, Abbott Australasia, AstraZeneca, Aventis Pharma, Janssen-Cilag, MSD (Australia), Pfizer Australia, Roche Products, Sanofi-Aventis, Wyeth Australia. The authors alone are responsible for the content and writing of the paper.